Tag: PTA Balloon Catheter

The Deputy mayor of Suzhou City visited Kossel Medtech (Suzhou) Co., Ltd.

On October 15th, the Deputy mayor of Suzhou City Qiao Zhang and his team visited Kossel Medtech (Suzhou) Co., Ltd. During the welcome meeting, CEO Arrow Hu introduced the company development journey, overseas market strategy and future planning, the government delegates also watched related videos, they discussed a lot about medical device raw materials, biological application materials, […]

The VTE Prevention training course was successfully held in Dongguan China

The first training course on the prevention and treatment of VTE was successfully held in Dongguan on Sept 24. ​Sponsored by Dongguan People’s Hospital and named by Kossel Medtech, an integrated enterprise with R&D capabilities in PTCA balloon catheter and PTA balloon catheter. Many prominent clinical experts and hospital administrators attended the conference to share […]

Haiwin Medtech (Suzhou) Co., Ltd. Held grand opening ceremony

Haiwin Medtech (Suzhou) Co., Ltd., which is a wholly-owned subsidiary, went into full operation on September 21st, the opening ceremony was held in a cool and sunny morning. Haiwin Medtech (Suzhou) Co., Ltd. is committed to providing systemic solutions for medical sheath tubes and catheter tubes. Their products include extrusion tube, semi-finished composite tube, PTFE […]

The Vascular Forum of Peking University came to a perfect end

The 2022 Peking University Vascular Forum, jointly sponsored and co-hosted by China-Japan Friendship Hospital, Peking University Third Hospital, Peking University First Hospital and Peking University People’s Hospital, was successfully held in Beijing from August 18 to 20. This Forum is an academic event with a certain scale and influence in China. It is one of […]

Launch conference of Kossel Falspeed® PTA Balloon dilatation catheter

Recently, at the 4th Jiangbei Water City Vascular Surgery conference, the launch meeting of the Falspeed® PTA balloon dilatation catheter was held. Marketing Director of Kossel Medtech Eva Pan said: The Falspeed® PTA balloon catheter as Kossel first peripheral product, was approved by the NMPA in June. Kossel Medtech peripheral field is subdivided into three […]

Falspeed®PTA balloon catheter was unveiled in a Conference

Recently, an excellent academic feast– the 4th China Hemorrhage Conference, which gathers domestic leading experts in this field and focuses on bleeding, was held in Changsha city. Kossel Medical attended the conference both online and offline. Professor Wang Qing from Hunan Provincial People’s Hospital was specially invited to share the related information online. The Octoparms®vena […]

The 11th Southwest Shandong Vascular Surgery Forum was successfully held

Recently, the 11th Southwest Shandong Vascular Surgery Forum was successfully held in Qufu, Shandong! Kossel Medtech actively participated in the meeting. At the meeting, the team of Director Wang Xu of the Department of Vascular Surgery of Jining First People’s Hospital reviewed the first implantation of Kossel Medtech’s Octoparms® Vena Cava Filter after its launch, […]

Layout three business segments to develop platform enterprises

Kossel MedTech is positioned as a platform enterprise with comprehensive R&D production capacity for vascular intervention. With a full range of balloon catheters, metal stents, drug-eluting stents, cryoablation and shockwave, and other passive and active technology platforms, including medical devices of 3 intervention categories of coronary, peripheral vascular, electrophysiology. Kossel MedTech is committed to developing […]

Kossel was selected into the list of key enterprises for intellectual property protection

Recently, Kossel Medtech has been successfully selected into the “Second Batch of Key Enterprises for Intellectual Property Rights Protection in Suzhou”. As a platform enterprise with full-scale production and R&D capabilities for vascular interventional devices, it has paid attention to the layout of intellectual property rights since its establishment, and has applied for it so […]